NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.88
-0.08 (-0.89%)
Mar 9, 2026, 3:25 PM EDT - Market open
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$290,933
Profits / Employee
-$43,210
Market Cap
1.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Neogen | 2,974 |
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
| Castle Biosciences | 883 |
NEO News
- 12 days ago - NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - Business Wire
- 19 days ago - NeoGenomics to Participate in Upcoming Investor Conferences - Business Wire
- 20 days ago - NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - NeoGenomics Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 25 days ago - NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection - Business Wire
- 5 weeks ago - NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - Business Wire
- 6 weeks ago - NeoGenomics: Distribution Moat In Community Oncology - Seeking Alpha
- 7 weeks ago - NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha